In a surprising twist, indie game Schedule I, a co-op crime simulation where players navigate their way from small-time dope pushers to kingpins, finds itself at the center of a copyright infringement controversy. The accuser, Movie Games S.A., developers of the The Drug Dealer Simulator series, alleges that Schedule I may have violated their IP rights. According to a report by the Polish Press Agency dated April 3, Movie Games S.A. claims that Schedule I has replicated their games' plot, mechanics, and user interface. However, despite these allegations, no official outcome has been released yet.
Interestingly, the gaming community has taken sides, predominantly supporting Schedule I. In a phenomenon known as review bombing, The Drug Dealer Simulator and its sequel have seen a surge in negative reviews on Steam, now rated as "Overwhelmingly Negative" and "Mostly Negative" respectively. Fans have voiced their discontent, accusing Movie Games S.A. of bullying the indie developer and pointing out the company's apparent hypocrisy. This backlash has occurred despite the series being highly praised as one of the best criminal management games in various reviews and fan circles.
Schedule I Recent Updates
Schedule I’s Copyright Infringement Accuser Gets Review Bombed on Steam
Launched into Early Access on PC on March 25, Schedule I has quickly gained traction, earning "Overwhelmingly Positive" reviews on Steam. It has secured its place as the platform's 2nd top-selling game, surpassing well-known titles like inZOI, Monster Hunter Wilds, and another indie gem, R.E.P.O.. SteamDB reports that Schedule I has reached an all-time peak of 459,075 concurrent players.
Here at Game8, we've found Schedule I to be a surprisingly addictive and rewarding experience, almost like a "Breaking Bad" simulator. To delve deeper into our impressions of Schedule I during its early access phase, feel free to explore our detailed article below!
